Risks of malignant lymphoma in rheumatoid arthritis patients receiving methotrexate-alone and in combination therapy compared with the general population: A study based on a Japanese medical claims database

Objective: The risk of malignancy in patients with rheumatoid arthritis (RA) treated with methotrexate (MTX) and biological disease-modifying antirheumatic drug (bDMARD) combination therapy is unknown. This study aimed to clarify the incidence of malignancy and the recommended monitoring period in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Inose, Ryo, Nakamura, Arisa, Omi, Rina, Takeno, Shujiro, Muraki, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548543/
https://www.ncbi.nlm.nih.gov/pubmed/37578124
http://dx.doi.org/10.5414/CP204372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548543/
https://www.ncbi.nlm.nih.gov/pubmed/37578124
http://dx.doi.org/10.5414/CP204372

Ejemplares similares